Structural Modification of Indole Derivatives as PknB Inhibitors for Enhanced Enzymatic Inhibition and Antimycobacterial Activity
Abstract
Protein kinase B (PknB) of Mycobacterium tuberculosis has emerged as a promising target for antituberculosis drug development. In our previous study, virtual screening combined with biological validation identified indole derivatives as novel PknB inhibitors with inhibitory activity against the growth of M. tuberculosis H37Rv, supporting a role for PknB inhibition in their antitubercular activity. Accordingly, the present study employed a structure-based drug design strategy using the previously identified indole scaffold as a template for optimization of PknB inhibitory activity and antimycobacterial potency. Twenty-seven indole derivatives were rationally designed and subjected to molecular docking calculations, which identified four candidates for chemical synthesis and evaluation of their inhibitory activity against M. tuberculosis growth and PknB. Three synthesized compounds (4b, 4c, and 4d) exhibited enhanced inhibition of M. tuberculosis growth, with minimum inhibitory concentration (MIC) values of 3.1 μg/mL, whereas compound 4a showed activity comparable to that of the parent indole (MIC = 6.2 μg/mL). All derivatives inhibited PknB activity with IC50 values ranging from 0.06 to 0.42 μM, which are comparable to that of the parent indole (IC50 = 0.45 μM). Notably, compound 4b demonstrated the highest potency against both M. tuberculosis growth and PknB activity, with an MIC value of 3.1 μg/mL and an IC50 value of 0.06 μM. Cytotoxicity evaluation against Caco-2 cells…
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.